CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population

被引:0
作者
Dogan, Ali [1 ]
机构
[1] Istanbul Yeni Yuzyil Univ, Fac Med, Gaziosmanpasa Hosp, Dept Cardiol, Cukurcesme C 51 Gaziosmanpasa Istanbul, TR-34245 Istanbul, Turkey
关键词
CLOPIDOGREL THERAPY;
D O I
10.1016/j.ijcard.2017.01.103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12 / 12
页数:1
相关论文
共 4 条
  • [1] Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans
    Lee, Jung Myung
    Park, Sungha
    Shin, Dong-Jik
    Choi, Donghoon
    Shim, Chi Young
    Ko, Young-Guk
    Kim, Jung-Sun
    Shin, Eun-Soon
    Chang, Chong Won
    Lee, Jong-Eun
    Jang, Yangsoo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01) : 46 - 51
  • [2] Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
    Scott, S. A.
    Sangkuhl, K.
    Gardner, E. E.
    Stein, C. M.
    Hulot, J-S
    Johnson, J. A.
    Roden, D. M.
    Klein, T. E.
    Shuldiner, A. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (02) : 328 - 332
  • [3] Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy
    Tantray, Javeed Ahmad
    Reddy, K. Pratap
    Jamil, Kaiser
    Kumar, Y. Shiva
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 229 : 113 - 118
  • [4] Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
    Trenk, Dietmar
    Hochholzer, Willibald
    Fromm, Martin F.
    Chialda, Ligia-Emilia
    Pahl, Andreas
    Valina, Christian M.
    Stratz, Christian
    Schmiebusch, Peter
    Bestehorn, Hans-Peter
    Buettner, Heinz Joachim
    Neumann, Franz-Josef
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (20) : 1925 - 1934